Fuzuloparib plus apatinib in BRCA-mutated breast cancer: balancing efficacy and accessibility in regional China
用户EO9nReo4Hj6s
1小时前
7
10
已关闭
DOI: 10.1016/s1470-2045(25)00752-1
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1470204525007521
其他信息:
出版社: Elsevier BV
作者: Ziran Qiu; Na Jin

